Brightstar Associates Llc - Net Worth and Insider Trading
Brightstar Associates Llc Net Worth
The estimated net worth of Brightstar Associates Llc is at least $502 Million dollars as of 2024-05-20. Brightstar Associates Llc is the 10% Owner of Deciphera Pharmaceuticals Inc and owns about 19,718,014 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $502 Million. Details can be seen in Brightstar Associates Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brightstar Associates Llc has not made any transactions after 2023-01-24 and currently still holds the listed stock(s).
Transaction Summary of Brightstar Associates Llc
Brightstar Associates Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brightstar Associates Llc owns 1 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) .
Click here to see the complete history of Brightstar Associates Llc’s form 4 insider trades.
Insider Ownership Summary of Brightstar Associates Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2023-01-24 | 10 percent owner |
Brightstar Associates Llc Latest Holdings Summary
Brightstar Associates Llc currently owns a total of 1 stock. Brightstar Associates Llc owns 19,718,014 shares of Deciphera Pharmaceuticals Inc (DCPH) as of January 24, 2023, with a value of $502 Million.
Latest Holdings of Brightstar Associates Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2023-01-24 | 19,718,014 | 25.46 | 502,020,636 |
Holding Weightings of Brightstar Associates Llc
Brightstar Associates Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Brightstar Associates Llc has made a total of 2 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the acquisition of 1,666,666 shares on January 24, 2023, which cost Brightstar Associates Llc around $30 Million.
Insider Trading History of Brightstar Associates Llc
- 1
Brightstar Associates Llc Trading Performance
GuruFocus tracks the stock performance after each of Brightstar Associates Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brightstar Associates Llc is 2.37%. GuruFocus also compares Brightstar Associates Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brightstar Associates Llc within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brightstar Associates Llc's insider trading performs compared to the benchmark.
Performance of Brightstar Associates Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.88 | | | | | |
| Relative Return to S&P 500(%) | -3.62 | | | | | |
Brightstar Associates Llc Ownership Network
Brightstar Associates Llc Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
Brightstar Associates Llc is the 10 percent owner of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include EVP & Chief Medical Officer Matthew L Sherman , Chief Financial Officer Thomas Patrick Kelly , and Chief Commercial Officer Daniel C. Martin .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, Brightstar Associates Llc made 1 insider transaction in Deciphera Pharmaceuticals Inc (DCPH) with a net purchase of 1,666,666. Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 26,559 shares made by Daniel C. Martin , a net sale of 14,587 shares made by Matthew L Sherman , and a net sale of 11,601 shares made by Thomas Patrick Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 154,121 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 1,687,666 shares were bought by its insiders, resulting in a net purchase of 1,533,545 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
Brightstar Associates Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Brightstar Associates Llc. You might contact Brightstar Associates Llc via mailing address: 1020 Central Street, Kansas City Mo 64105.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
